The regulation of gene expression involved in TGF-β signaling by ZNF804A, a risk gene for schizophrenia

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 273-278

  Umeda Yano, Satomi ^a   Hashimoto, Ryota ^a,b,c   Yamamori, Hidenaga ^a   Okada, Takeya ^a   Yasuda, Yuka ^a,b   Ohi, Kazutaka ^a,b   Fukumoto, Motoyuki ^a   Ito, Akira ^a   Takeda, Masatoshi ^a,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

ANKRD1; DDIT3; INHBE; PIK3AP1; TGF ; ZNF804A

Indexed keywords

ADAPTOR PROTEIN; ANKYRIN; ANKYRIN REPEAT DOMAIN 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INHIBIN; PHOSPHOINOSITIDE 3 KINASE ADAPTOR PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 804A;

ANKRD1 GENE; ARTICLE; BIRC3 GENE; CLIC2 GENE; CONTROLLED STUDY; DDIT3 GENE; DOWN REGULATION; EMBRYO; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INHBE GENE; MGAM GENE; NUCLEOTIDE SEQUENCE; PIK3AP1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UPREGULATION; ZNF804A GENE;

CELL LINE, TRANSFORMED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84875965781     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.026     Document Type: Article

References (50)

1. Ageta H., Murayama A., Migishima R., Kida S., Tsuchida K., Yokoyama M., Inokuchi K. Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS One 2008, 3(4):e1869.
2. Bajestan S.N., Sabouri A.H., Nakamura M., Takashima H., Keikhaee M.R., Behdani F., Fayyazi M.R., Sargolzaee M.R., Bajestan M.N., Sabouri Z., Khayami E., Haghighi S., Hashemi S.B., Eiraku N., Tufani H., Najmabadi H., Arimura K., Sano A., Osame M. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(4):383-386.
3. Benes F.M., Lim B., Matzilevich D., Walsh J.P., Subburaju S., Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(24):10164-10169.
4. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125(1-2):279-284.
5. Bennett M.R. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog. Neurobiol. 2011, 95(3):275-300.
6. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 2000, 97(1):12-17.
7. Chu W., Burns D.K., Swerlick R.A., Presky D.H. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem. 1995, 270(17):10236-10245.
8. Colak D., Mori T., Brill M.S., Pfeifer A., Falk S., Deng C., Monteiro R., Mummery C., Sommer L., Gotz M. Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J. Neurosci. 2008, 28(2):434-446.
9. Donohoe G., Morris D.W., Corvin A. The psychosis susceptibility gene ZNF804A: associations, functions, and phenotypes. Schizophr. Bull. 2010, 36(5):904-909.
10. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36(2):131-137.
11. Girgenti M.J., Loturco J.J., Maher B.J. ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. PLoS One 2012, 7(2):e32404.
12. Hashimoto O., Tsuchida K., Ushiro Y., Hosoi Y., Hoshi N., Sugino H., Hasegawa Y. cDNA cloning and expression of human activin betaE subunit. Mol. Cell. Endocrinol. 2002, 194(1-2):117-122.
13. Hashimoto O., Ushiro Y., Sekiyama K., Yamaguchi O., Yoshioka K., Mutoh K., Hasegawa Y. Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. Biochem. Biophys. Res. Commun. 2006, 341(2):416-424.
14. Hashimoto O., Sekiyama K., Matsuo T., Hasegawa Y. Implication of activin E in glucose metabolism: transcriptional regulation of the inhibin/activin betaE subunit gene in the liver. Life Sci. 2009, 85(13-14):534-540.
15. Hashimoto R., Ohi K., Yasuda Y., Fukumoto M., Iwase M., Iike N., Azechi M., Ikezawa K., Takaya M., Takahashi H., Yamamori H., Okochi T., Tanimukai H., Tagami S., Morihara T., Okochi M., Tanaka T., Kudo T., Kazui H., Iwata N., Takeda M. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(8):1459-1464.
16. Hill M.J., Jeffries A.R., Dobson R.J., Price J., Bray N.J. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum. Mol. Genet. 2011, 21(5):1018-1024.
17. Hollander J.A., Im H.I., Amelio A.L., Kocerha J., Bali P., Lu Q., Willoughby D., Wahlestedt C., Conkright M.D., Kenny P.J. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010, 466(7303):197-202.
18. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ozaki N. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry 2004, 56(9):698-700.
19. Jia P., Wang L., Meltzer H.Y., Zhao Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr. Res. 2010, 122(1-3):38-42.
20. Kanai H., Tanaka T., Aihara Y., Takeda S., Kawabata M., Miyazono K., Nagai R., Kurabayashi M. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circ. Res. 2001, 88(1):30-36.
21. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee H.J., Kim D.J., Leonard B.E. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28(7):1129-1134.
22. Konig H.G., Kogel D., Rami A., Prehn J.H. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J. Cell Biol. 2005, 168(7):1077-1086.
23. Liu A., Niswander L.A. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat. Rev. Neurosci. 2005, 6(12):945-954.
24. Massague J. TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 1996, 85(7):947-950.
25. Miller M.K., Bang M.L., Witt C.C., Labeit D., Trombitas C., Watanabe K., Granzier H., McElhinny A.S., Gregorio C.C., Labeit S. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J. Mol. Biol. 2003, 333(5):951-964.
26. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
27. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
28. Ohi, K., Hashimoto, R., Yasuda, Y., Fukumoto, M., Nemoto, K., Ohnishi, T., Yamamori, H., Takahashi, H., Iike, N., Kamino, K., Yoshida, T., Azechi, M., Ikezawa, K., Tanimukai, H., Tagami, S., Morihara, T., Okochi, M., Tanaka, T., Kudo, T., Iwase, M., Kazui, H., Takeda, M., in press. The AKT1 gene is associated with attention and brain morphology in schizophrenia. World J. Biol. Psychiatry.
29. Ohi K., Hashimoto R., Yasuda Y., Fukumoto M., Yamamori H., Umeda-Yano S., Okada T., Kamino K., Morihara T., Iwase M., Kazui H., Numata S., Ikeda M., Ohnuma T., Iwata N., Ueno S.I., Ozaki N., Ohmori T., Arai H., Takeda M. Functional genetic variation at the NRGN gene and schizophrenia: evidence from a gene-based case-control study and gene expression analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012, 159B(4):405-413.
30. Okada T., Maeda A., Iwamatsu A., Gotoh K., Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 2000, 13(6):817-827.
31. Okada T., Hashimoto R., Yamamori H., Umeda-Yano S., Yasuda Y., Ohi K., Fukumoto M., Ikemoto K., Kunii Y., Tomita H., Ito A., Takeda M. Expression analysis of a novel mRNA variant of the schizophrenia risk gene ZNF804A. Schizophr. Res. 2012, 141(2-3):277-278.
32. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004, 11(4):381-389.
33. Park S.M., Jung J.S., Jang M.S., Kang K.S., Kang S.K. Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells. Cell Prolif. 2008, 41(2):248-264.
34. Pereira R.C., Delany A.M., Canalis E. CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 2004, 145(4):1952-1960.
35. Qu M., Tang F., Wang L., Yan H., Han Y., Yan J., Yue W., Zhang D. Associations of ATF4 gene polymorphisms with schizophrenia in male patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(6):732-736.
36. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D., Kendler K.S. Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample. Mol. Psychiatry 2010, 15(1):29-37.
37. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000, 23(12):618-625.
38. Schanze D., Ekici A.B., Gawlik M., Pfuhlmann B., Reis A., Stober G. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156(2):198-203.
39. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 2005, 58(6):446-450.
40. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113(6):685-700.
41. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
42. Steinberg S., Mors O., Borglum A.D., Gustafsson O., Werge T., Mortensen P.B., Andreassen O.A., Sigurdsson E., Thorgeirsson T.E., Bottcher Y., Olason P., Ophoff R.A., Cichon S., Gudjonsdottir I.H., Pietilainen O.P., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Athanasiu L., Suvisaari J., Lonnqvist J., Paunio T., Hartmann A., Jurgens G., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Breuer R., Moller H.J., Giegling I., Glenthoj B., Rasmussen H.B., Mattheisen M., Bitter I., Rethelyi J.M., Sigmundsson T., Fossdal R., Thorsteinsdottir U., Ruggeri M., Tosato S., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Walshe M., Bramon E., Vassos E., Li T., Fraser G., Walker N., Toulopoulou T., Yoon J., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Peltonen L., Rujescu D., Collier D.A., Stefansson H., St Clair D., Stefansson K. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol. Psychiatry 2011, 16(1):59-66.
43. Uranova N.A., Vostrikov V.M., Vikhreva O.V., Zimina I.S., Kolomeets N.S., Orlovskaya D.D. The role of oligodendrocyte pathology in schizophrenia. Int. J. Neuropsychopharmacol. 2007, 10(4):537-545.
44. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3(7). (RESEARCH0034).
45. Watanabe Y., Someya T., Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin. Neurosci. 2010, 64(3):217-230.
46. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its 0involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2010, 16(4):429-441.
47. Yamamori H., Hashimoto R., Verrall L., Yasuda Y., Ohi K., Fukumoto M., Umeda-Yano S., Ito A., Takeda M. Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia. J. Hum. Genet. 2011, 56(7):478-483.
48. Yasuda Y., Hashimoto R., Ohi K., Fukumoto M., Umeda-Yano S., Yamamori H., Okochi T., Iwase M., Kazui H., Iwata N., Takeda M. Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene. Neurosci. Lett. 2011, 495(3):216-220.
49. Yasuda Y., Hashimoto R., Yamamori H., Ohi K., Fukumoto M., Umeda-Yano S., Mohri I., Ito A., Taniike M., Takeda M. Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder. Mol. Autism 2011, 2(1):9.
50. Zhang R., Lu S.M., Qiu C., Liu X.G., Gao C.G., Guo T.W., Valenzuela R.K., Deng H.W., Ma J. Population-based and family-based association studies of ZNF804A locus and schizophrenia. Mol. Psychiatry 2011, 16(4):360-361.